Ann Tan
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Richard D. Kim (5 shared papers)Federico Aucejo (6 shared papers)Lisa A Rybicki (2 shared papers)Minsig Choi (1 shared paper)Richard Kim (2 shared papers)Bassel F. El‐Rayes (1 shared paper)Paul J. Elson (2 shared papers)Ramon M. Esclamado (1 shared paper)
- Journals
- Oncology (2 papers)Liver Transplantation (1 paper)Current Oncology Reports (1 paper)ANZ Journal of Surgery (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Ann Tan
15 papers receiving 668 citations
Ann Tan's Hit Papers
Peers
Comparison fields: 5 of 48
- Otorhinolaryngology 54
- Gastroenterology 56
- Hepatology 68
- Oncology 193
- Pulmonary and Respiratory Medicine 213
Countries citing papers authored by Ann Tan
This map shows the geographic impact of Ann Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Tan more than expected).
Fields of papers citing papers by Ann Tan
This network shows the impact of papers produced by Ann Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Tan. The network helps show where Ann Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial Hit paper breakdown → | 2023 | 435 |
| 2 | 2007 | 62 | |
| 3 | 2011 | 43 | |
| 4 | 2010 | 42 | |
| 5 | 2013 | 35 | |
| 6 | 2014 | 21 | |
| 7 | 2010 | 19 | |
| 8 | 2010 | 14 | |
| 9 | Adjuvant treatment after orthotopic liver transplantation: is it really necessary? | 2009 | 4 |
| 10 | Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center. | 2012 | 2 |
| 11 | Serum Vascular Endothelial Growth Factor Level in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Experience of a Single Western Center | 2012 | 2 |
| 12 | 2008 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 1997 | 1 | |
| 16 | 2009 | 0 | |
| 17 | 2025 | 0 |
About Ann Tan
Ann Tan is a scholar working on Hepatology, Cancer Research, Oncology, Surgery and Otorhinolaryngology, having authored 17 papers that have together received 683 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Angiogenesis and VEGF in Cancer (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Mechanisms and Therapy (1 paper), Cancer Genomics and Diagnostics (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Pregnancy and preeclampsia studies (1 paper). The work is most often cited by research in Otorhinolaryngology (54 citations), Gastroenterology (56 citations), Hepatology (68 citations), Oncology (193 citations) and Pulmonary and Respiratory Medicine (213 citations). Ann Tan has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Richard D. Kim, Federico Aucejo, Lisa A Rybicki, Minsig Choi, Richard Kim, Bassel F. El‐Rayes, Paul J. Elson, Ramon M. Esclamado, Marshall Strome and David J. Adelstein. Their work appears in journals such as Oncology, Liver Transplantation, Current Oncology Reports, ANZ Journal of Surgery and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.